| Date | Title | Description |
| 01.10.2025 | Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD Oncology Kits in Europe | Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using Droplet Digital™ PCR (ddPCR™) for Clinical Testing of Critical Oncology Biomarkers
HERCULES, Calif. & SEOUL, South... |
| 12.10.2023 | Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test | SEOUL, South Korea, Oct. 12, 2023 /PRNewswire/ -- Gencurix, a cancer molecular diagnostics company, has obtained approval from the Australian Government (The Department of Health and Aged Care, Therapeutic Goods Administration) for its Drop... |
| 14.06.2023 | Gencurix Obtains Approval for Companion Diagnostic of Digital PCR-based EGFR Mutation Test | SEOUL, South Korea, June 14, 2023 /PRNewswire/ -- Gencurix, a leading cancer molecular diagnostics company, has obtained approval from the Korean Ministry of Food and Drug Safety for its Droplex EGFR Mutation Test v2. This product is a comp... |
| 07.06.2023 | Gencurix Announces Clinical Research Results At ASCO Demonstrating Outstanding Performance of GenesWellBCT Compared to Global Best-Selling Test, OncotypeDX | SEOUL, South Korea, June 7, 2023 /PRNewswire/ -- Gencurix announced the release of clinical research results comparing the accuracy of its breast cancer prognostic test, GenesWellBCT, with OncotypeDX, the globally top-selling test, confirmi... |
| 05.06.2023 | Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company's Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, Onc... | SEOUL, South Korea, June 4, 2023 /PRNewswire/ -- Gencurix (KOSDAQ #229000), a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly comparing the accuracy of its breast cancer prognost... |
| 10.05.2023 | Gencurix announced Korean and Japanese cancer patients' 15-year follow-up prognostic test clinical results | SEOUL, South Korea, May 9, 2023 /PRNewswire/ -- Gencurix announced clinical results of its prognostic test for breast cancer patients at the Global Breast Cancer Conference 2023. The study, 'Long-term prognostic value of GenesWellBCT score ... |
